3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord Lesions

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02896647

Acronym

ESPOIR

Enrollment

Registered

2016-09-12

Start date

2016-12-14

Completion date

2018-09-30

Last updated

2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

This study aims to assess the interest of 3D Phase Sensitive Inversion Recuperation (PSIR)sequence in the MRI detection of spinal cord lesion. It will compare the sensitivity of this MRI sequence compared to the T1 and T2 sequences recommended in the assessment of neuraxis inflammatory diseases.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age ≥ 18 years old * patients scheduled for spinal cord MRI exploration for the assessment of neuraxis inflammatory diseases

Exclusion criteria

* contraindication to MRI * allergy to contrast media * patient under legal protection * no health insurance coverage * patient's refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
number of spinal cord lesions	baseline

Countries

France

Outcome results